The blueprint for cellular diversity and response to environmental change is encoded in the cis-acting regulatory sequences of most genes. Deciphering this 'cis-regulatory code' requires multivariate data sets that examine how these regions coordinate transcription in response to diverse environmental stimuli and therapeutic treatments. We describe a transcriptional approach that profiles the activation of multiple transcriptional targets against combinatorial arrays of therapeutic and signal transducing agents. Application of this approach demonstrates how cis-element composition and promoter context combine to influence transcription downstream of mitogeninduced signaling networks. Computational dissection of these transcriptional profiles in activated T cells uncovers a novel regulatory synergy between IGF-1 and CD28 costimulation that modulates NF-kB and AP1 pathways through signaling cascades sensitive to cyclosporin A and wortmannin. This approach provides a broader view of the hierarchical signal integration governing gene expression and will facilitate a practical design of combinatorial therapeutic strategies for exploiting critical control points in transcriptional regulation.
INTRODUCTION
The capacity for cellular diversity is linked to its extraordinary ability to respond rapidly to changes in the environment. Although unique to every species, this property cannot be accounted for by mere gene number. 1 One central source of this diversity is the integrated control of gene transcription, a process that is primarily directed at the level of the cis-regulatory regions of all genes. 2 Thus, a major challenge for biomedical research in the postgenomic era will be to identify, decipher, and understand the 'languages' or 'codes' that coordinate the spatial, temporal, and kinetic patterns of gene transcription. 3 Current platforms for studying gene expression, including differential display, SAGE, and cDNA microarray, profile steady-state differences in the mRNA population or 'transcriptome' in response to environmental change and disease. Although highly informative and predictive, these data sets represent averaged summations of pre-, peri-, and post-transcriptional events and thus only partially reflect active transcription of targeted genes. The goal of understanding how the elements of promoter sequence and structure contribute to transcriptional control will therefore require additional empirical data sets that more directly measure the dynamics of stimulus-evoked changes at the level of activated transcription.
A central structural feature of the regulatory logic of cisregulatory regions is their combinatorial nature. 3 Most promoters and gene regulatory regions are comprised of an integrated network of modular or 'composite' transcription factor binding sites. [3] [4] [5] [6] [7] Control of this network is hierarchical and progressive. Multiple transcription factors bind to composite modules in a linked or coordinated manner. Composite modules then function as constituents within larger, more integrated frameworks to form expanded interactions with other distant cis-regulatory regions. Hierarchical control of the inducible recruitment and assembly of transcription factor complexes at these regulatory regions is the primary target of signal transduction and determines the unique spectrum of the cell's transcriptional response to environmental challenge. 2, 3 The dynamic regulation of the interleukin 2 (IL2) promoter during T-cell activation represents a well-established paradigm for understanding how the combinatorial logic of cis-regulatory regions integrates the signal transduction cascades initiated during the immune response. [7] [8] [9] [10] [11] The molecular signaling events triggered during T-cell activation comprise a diverse array of intersecting and overlapping pathways. 12 Classically, this process begins with the initiation of two qualitatively distinct interactions at the T-cell surface. The first occurs when the antigen receptor engages antigen in the context of a major histocompatibility complex type II (MHC class II) molecule of an antigenpresenting cell. This event initiates multiple intracellular tyrosine phosphorylation cascades at the T-cell surface that result in phospholipase Cg activation, subsequent phosphatidyl inositol-4,5 bisphosphate cleavage (PI-4,5-P 2 ), elevation of diacylglycerol, increased inositol triphosphate levels, calcium influx, protein kinase C activation, and upregulation of Ras/mitogen-activated kinase pathways (for review, see Nel and Slaughter 12 ). The process is routinely mimicked in vitro by the combined addition of pharmacological mitogens such as the calcium ionophore, ionomycin, and the phorbol ester, phorbol myristate acetate (PMA) 13 (see Figure 1a and b). Other combinations commonly used to generate the first signal include the addition of PMA in the combination with surface receptor crosslinking lectins such as phytohemagglutinin (PHA) or antibodies against the CD3 component of the T-cell receptor. 13 The second signal is derived from ligation of T-cell surface accessory molecules. One of them is the CD28 coreceptor, which binds to its CD80/CD86 counter-receptors on the antigen-presenting cell.
14 Ligation of the CD28 receptor increases tyrosine phosphorylation of its intracellular domain with subsequent elevation of phosphatidyl-inositol-3 phosphate kinase (PI3-kinase) activity and induction of Rho/Rac pathways. 8 This interaction can be mimicked in the absence of antigen-presenting cells by the addition of monoclonal antibodies that crosslink the CD28 receptor. 15 Together, these receptor interactions and their downstream signaling cascades converge to initiate events that control the nuclear assembly of transcriptional complexes at the IL2 promoter and other genes targeted during the immune response.
Lineage-specific and correct position-independent regulation of the IL2 promoter requires a segment of the IL2 locus that is 8 kb upstream of transcription. 16 A well-characterized 300 base pair (bp) segment within the proximal portion of this region confers much of the responsiveness of the IL2 gene to immune initiated molecular signaling events. 9 This proximal promoter is comprised of a series of composite cisregulatory modules (Figure 1a and c) . Consistent with the combinatorial logic that is now recognized as a common regulatory strategy for most genes, each of the composite elements within the IL2 proximal promoter can bind two or more different factors in a linked or cooperative fashion to influence transcription. 4, 8, 9 Interestingly, these nuclear factors are a unique mixture of both lineage-specific and ubiquitous regulators that respond distinctly to signal transduction events commonly initiated during the immune response (Figure 1a and c). 8, 9 Although much is known about the individual molecular signaling events, pathways, and their specific nuclear targets, few studies clearly profile how these events and their downstream targets are integrated to influence transcription.
RESULTS

Computational Dissection of T-cell Transcriptional Activation Profiles
To more clearly evaluate the molecular integration of events at the IL2 promoter, we developed a high-throughput transcriptional approach capable of assessing the influence of simultaneous mitogen and drug combinations during Tcell activation. In this method, Jurkat T-lymphocytes are transfected with eight different reporter constructs containing the IL2 promoter, its composite modules (NFAT/AP1 and CD28RE/AP1), consensus versions of its constituent submodules (CRE, AP1, and NF-kB), and expression vectors encoding associated factors (p300) known to assemble at the IL2 promoter during T-cell activation 6, 7 (Figure 1a and b). Transfected cells are then individually challenged with 16 different combinations of known T-cell mitogens (listed in Figure 1a and c). The resulting mitogen response profile is analyzed in the presence of seven different immunomodulatory pharmacological agents (Figure 1a) . The net result of this analysis is an 8 Â 128 heat diagram representing the activation profile of eight reporters (transcriptional targets) against 128 conditions (Figure 1c) .
The heat map shown in Figure 1c reveals various distinct trends in the transcriptional activation of each reporter. However, such differences and similarities are more effectively compared by the use of a variety of computational methods designed to reveal quantitative trends in multivariate data. Hierarchical clustering is a commonly used analytical approach for identifying functional correlations in high-dimensional data. 17 Application of hierarchical clustering to the transcriptional data shown in Figure 1c produces very distinctive patterns or 'fingerprints' representing how each immunomodulatory agent influences mitogen-activated transcriptional control during T-cell activation (Figure 2a and b) . Dendrogram comparison of the manner in which each transcriptional target (reporter) responds to the drug-induced changes identifies unexpected divergent relationships in the mitogen/drug responsiveness of the IL2 promoter and its constituent elements (Figure 2a , right, and Supplement 1). One striking observation is that although there are multiple binding sites for AP1 within the IL2 promoter (see Figure 1b and Jain et al 9 for review), the transcriptional response of AP1 alone is clearly distinct from that of IL2. Similarly, although the IL2 promoter is well known to be controlled by members of the nuclear factor of activated T cells (NFAT) family and NF-kB, the relative response of isolated NFAT and NF-kB pathways shows clear differences from IL2 (Figure 2a, right) . In contrast, the CD28RE/AP1 element of the IL2 promoter, a composite module that cooperatively assembles NF-kB family members in conjunction with members of the AP1 and CREB family, 7, 10, 18 shows the greatest similarity to IL2 (Figure 2a , right). Such observations highlight the importance of 'combinatorial logic' in the hierarchy of promoter structure. 3, 4, 6, 7, 19 Cyclosporin A (CSA) and the SB203580 p38 MAP kinase inhibitor are agents frequently used to broadly influence leukocyte activation in vitro and in vivo, yet many details of their mode of action remain unresolved. 20, 21 A focused comparison of their influences on mitogen-induced transcriptional pathways in T cells shows that their effects are dramatically distinct and highlights several functional aspects of the transcriptional pathways that account for their class separation (Figure 2b ). Hierarchical clustering of the transcriptional profiles generated by these drugs reveals a class separation of transcriptional pathways that is very similar to Figure 2a . Again, AP1, NFAT, and NF-kB pathways are distinct from IL2, while the response of composite CD28RE/AP1 elements is most similar to IL2. To explore the possible functional mechanisms underlying this type of class separation, we employed the method of unsupervised neural networks (self-organizing maps (SOM)). 22 SOM is a class separation algorithm that begins with a simple grouping topology such as a two-dimensional grid of nodes (Figure 2c , top). It refines this grouping based on the transcriptional properties of the response elements by comparing their mitogen and drug profiles through an iterative calculation that places reporters with similar patterns as neighbors within a single node or class. 22 Those members that remain in the same node after repeated iteration series are closely related. Those that appear to change after repeated iteration series are less related and instead may have features common to multiple nodes. Figure 2c contains a two-dimensional grid with four nodes corresponding to four transcriptional target groups based on how they respond to the mitogens in the absence or presence of either SB or CSA. Once again, the CD28RE/AP1 element and IL2 are classified together, NFAT/AP1 and NFkB are classified separately, and AP1 is partitioned into a class by itself. Centroid plots provide functional explanations for the grouping by showing consensus response profiles of the four classes (Figure 2c, bottom ). These profiles demonstrate that a major class-defining functional determinant of AP1 (when comparing transcriptional responses gated under control, CSA, and SB203580 treatment) is its paradoxical stimulation by the immunosuppressant CSA (Figure 2c , blue line). In contrast, the grouping of NFAT/AP1 and NF-kB results from their mutual strong inhibition by CSA (Figure 2c , red line). Similar grouping was obtained in multiple iteration series (Supplement 2).
One notable discrepancy between the two analyses (hierarchical cluster vs SOM) is the separation of the p300 full-length and p300 N-terminal GAL4 hybrid response profiles. The p300 reporter assay uses an expression vector containing a fusion between the DNA binding domain of Gal4 and either full-length p300 (p300 FL) or the N-terminal 743 amino acids of p300 (p300 N-term, 1-743). The Gal4p300 vector is cotransfected with a luciferase reporter containing tandem copies of the binding site for Gal4 (UAS). The resulting combination is a sensor for changes in the intrinsic transcriptional activity of p300, a known target of signal transduction pathways in activated T cells. 6, 23 In contrast to the dendrogram assignments from Figure 2a and b, the p300 N-terminal transcriptional response (lacking the C-terminus) is classified differently from that of the fulllength p300, which is grouped with NF-kB and NFAT/AP1 ( Figure 2c ). As mentioned above, a key feature of this class is sensitivity to CSA (Figure 2c , red line). This separate classification of the two p300 GAL4 fusions suggests that the p300 C-terminus confers greater sensitivity to CSA repression (Figure 2b and c) , as has been suggested for the C-terminus of CBP, the paralog of p300.
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Results from two iteration series of SOM for the transcriptional targeting under all eight conditions are shown in Figure 3 . Again, IL2 and CD28RE/AP1 are shown to remain classified together. Also apparent from this broader analysis is the greater similarity in response profiles of AP1 and CREB. This is due to the observation that both pathways are relatively more stimulated in the presence of CSA and wortmannin ( Figure 3 , left, yellow line; and Figure 3 , right, red line), a major determinant responsible for their grouping together. Another common characteristic of CD28RE/AP1 and IL2 demonstrated by the SOM in Figure 3 is their relative resistance to forskolin repression and intermediate sensitivity to CSA repression ( Figure 3 , left, blue line; and Figure 3 , right, yellow line). This is a reflection of the contributing role played by both CREB and AP1 pathways in mediating transcription from both the IL2 promoter and its CD28RE/AP1 element. 7, 10 Although the elevated cAMP associated with forskolin is a well-known repressor of IL2 and plays an important role in anergy, 24, 25 this repression appears to represent an integration of both stimulatory (CREB) and inhibitory (NFAT/AP1, NF-kB, and p300) influences at the IL2 promoter (see Figure 5 , bottom).
Principal Component Analysis Maps Regulatory Trends in Complex Data Sets
Principal component analysis (PCA) is a computational method that facilitates the interpretation of multidimensional data by presenting them in reduced dimensions. 19, 26 This simplification is represented graphically by a plot, displaying 3 or fewer dimensions, that summarizes the similarities and differences between variables by their relative spatial separation. An eigenvector calculation is used to 'remap' the transcriptional data in composite dimensions or 'principal components' that capture most of the characteristics of the data (for more complete description, see Supplement 3). Results of a focused PCA comparison of the transcriptional profiles of control (red), CSA (green), and SB203580 (orange) treated Jurkat cells are represented by the three-dimensional (three axes) plot shown in Figure 4a . Each axis corresponds to a principal component (PC). The data spheres represent a statistical averaging of how each mitogen combination collectively influenced the activity of eight different reporter elements projected in a three-dimensional space where each axis (PC) is a composite of the original transcriptional data from the eight different reporters. By this new mapping, the relative distance between points provides an objective comparison of the degree of similarity between the transcriptional targeting of each mitogen combination. Thus, the relative clustering and dispersion of the profiled points provide very specific information on the influences of the individual drugs. For example, the spread of the transcriptional profile in the presence of CSA (green) is consistent with its selective mode of action. 27 In contrast, the compacted clustering of the profile in the presence of SB203580 suggests that its effects are either more global, occurring at proximal points in signal cascades, or are nonspecific. The three-dimensional space of the PCA can be functionally mapped by examining the eigenvector coefficients for each PC (Figure 4c ). The absolute size of the eigenvector coefficients (whether negative or positive) is proportional to the relative contribution of its transcriptional pathway (ie AP1, NFAT/AP1, NF-kB, CRE, IL2, CD28RE/AP1, p300FL, or p300 N-term) to its respective dimension (PC axis). For example, the magnitude of the eigenvector coefficients in PC one (PC1) is rather uniform (Figure 4c , gray bars). This indicates that the different transcriptional targets contribute equally to this axis. The distance between data points along this axis reflects difference in total transcriptional magnitude and does not distinguish between the transcriptional pathways or targets. The separation of data points in the direction of the vertical dimension (PC two (PC2)) has major eigenvector contributions from NFAT/AP1 and NF-kB (lavender bars) with strong contribution from AP1 and CREB pathways that are opposite in direction (ie anticorrelated). This indicates that the separation of data points in the vertical direction is primarily due to changes in NFAT/AP1 and NF-kB targeting with contributions that are opposite (anticorrelated) in direction from AP1 and CREB. This anticorrelation means that changes in the vertical direction (PC2) for the data points are mainly due to influences on NFAT/AP1 and NF-kB pathways that are accompanied by opposing changes (ie stimulation vs inhibition) for AP1 and CREB pathways. Accordingly, the downward projection of the control data points after CSA treatment (red to green) represents changes consistent with inhibition of NFAT/AP1 and NF-kB and anticorrelated stimulation of AP1 and CREB (see Figures 2b and 4a ). This corroborates the conclusions from the hierarchical clustering and SOM analyses (Figures 2 Figure 3 SOM analysis of the complete array of mitogen/drug combinations. Open arrows indicate peak of transcriptional induction in the presence of wortmannin. Closed arrow indicates transcriptional induction in the presence of CSA. Asterisks indicate peak of differential resistance to repression by forskolin (see Figure 5 ). and 3) and published observations that CSA inhibits NFAT/ AP1 and NF-kB. 27, 29 The divergent influence of CSA on AP1 and CREB is unexpected especially since the NFAT/AP1 module contains a well-known AP1 element. Once again, this observation illustrates how the combinatorial nature of cis-element composition can dramatically influence the response to external stimuli.
The third dimensional axis (PC three (PC3)) shown in Figure 4b has major contribution from the CD28RE/AP1 and NF-kB transcriptional targets with prominent anticorrelated contribution from AP1 and NFAT/AP1 (Figure 4c , green bars). Accordingly, the separation of the data points along this PC axis arises primarily from transcriptional influences that stimulate CD28RE/AP1 and NF-kB with concomitant relative repression of AP1 and NFAT/AP1. The lateral displacement of the blue data spheres (1-4) relative to the red spheres along PC3 is therefore consistent with preferential stimulatory targeting of NF-kB and CD28RE/AP1 (Figure 4b, arrows) . This functional mapping clarifies the functional origin of these four outliers and suggests that IGF-1 treatment acts in synergy with CD28 costimulation to induce transcriptional activation of NF-kB pathways and the CD28RE/AP1 module of the IL2 promoter.
The biplot projection is an adaptation of PCA that rapidly profiles the preferential targeting of the drugs while also indicating their relative synergy or antagonism with each respective transcriptional regulatory module ( Figure 5 and Supplement 5). Data sphere position, relative to the axes, reveals the promoter elements preferentially targeted by the drugs. The sizes of the data spheres are in proportion to the magnitude of activation in response to each mitogen/drug combination at the indicated promoter module (Figure 5a , NFAT/AP1, CD28RE/AP1, NF-kB, and AP1; Figure 5b , CREB, IL2, p300 FL, and p300 N-term). Thus, relative synergy (larger spheres) and antagonism (smaller spheres) are made readily apparent. The distance of the spheres from the central intersection of the axes is proportional to the overall magnitude of transcriptional response produced by the mitogen/drug combination. In addition to clearly illustrating the paradoxical targeting of CSA (inhibition of NFAT/ AP1 and NF-kB accompanied by stimulation of AP1; Figure  5a , green spheres), this method also reveals a similar divergent targeting by the PI3-kinase inhibitor, wortmannin (Figure 5a , yellow spheres) consistent with the influences depicted by the SOM of Figure 3 . The parallel behavior of these drugs suggests a possible functional convergence of PI3-kinase effectors and calcineurin regulated events (see Discussion). The strong selective synergy between IGF-1 and the NF-kB and CD28RE/AP1 elements in the presence of CD28 costimulation is well illustrated (Figure 5a , enumerated larger blue spheres). Notably, the ability of IGF-1 to synergize with CD28 requires TCR-induced pathways in combination with PMA. Neither a-CD28 alone, IGF-1 alone nor IGF-1 combined with a-CD28 has significant influence on transcription (Figure 2a ). This suggests that IGF-1 signaling in T cells may well be considered a bona fide costimulatory event. 30 Interestingly, the biplot analysis of Figure 5b shows that forskolin targeting behavior at the CREB binding site CRE and IL2 converge (see circled spheres). The stimulation of CREB pathways combined with the relative resistance of the IL2 promoter to forskolin (in comparison to NFAT/AP1 and NF-kB) is a contributing factor to this similarity. As discussed above, this is consistent with previous hierarchical clustering data (Figures 2a and b , and Supplement 1) and the published role for CREB transcriptional pathways in control of the IL2 promoter. 7, 19, 24, 31, 32 Drug Classifications Defined by Transcriptional Targeting Comparative analysis of two-dimensional PCA profiles provides a useful way to compare and distinguish the differential transcriptional targeting by each drug ( Figure  6 ). Figure 6a compares the control and seven different drugs, based on how they influence the transcriptional activity of the eight transcriptional targets (reporters) in the presence of the 16 different mitogen combinations (128 conditions), by two-dimensional PCA. The closeness of the wortmannin and IGF-1 points in the PC1 Â PC3 plot (Figure 6a , left) suggests that these agents target similar pathways. Indeed, both agents influence PI3-kinase-dependent pathways (IGF-1 positively and wortmannin negatively). 33 Similarly, the PC1 Â PC3 plot suggests some similar features of transcriptional targeting by CSA and the MEK1 inhibitor PD90859 while also implying an overlapping transcriptional influence between the p38 MAP kinase inhibitor SB203580 and the protein kinase C inhibitor rottlerin. Table 1 contains a tabulation of the relative percent contribution of each transcriptional target summed from its contribution under each mitogen combination. Similar to Figure 4c , this tabulation indicates the relative contribution (in percent) of each transcriptional target to the separation of data points along each PC dimension (axis). An analysis of Table  1 shows that p300, AP1, NFAT/AP1, and CREB make major contributions to PC1, while CRE, CD28RE/AP1, AP1, and IL2 transcriptional activities make major contributions to PC3. Thus, the close pairing of the drugs in the PC1 Â PC3 PCA plot described above can be explained in part by their similar regulatory influence on these pathways. The increased vertical separation of forskolin from the other drugs along PC3 is accounted for by the relative resistance and/or stimulation of CRE, CD28RE/AP1, AP1, and IL2 pathways in the presence of forskolin in comparison to the other pathways as suggested by the biplots of Figure 5 . These relationships change in the PC2 dimension where the eigenvector coefficients contributed by AP1 are by far the major contributors to the axis separation (Table 1 and Figure  6b ) and the contribution by NF-kB rises dramatically (1-19%). Thus, IGF-1 and wortmannin show correlated targeting that diverges significantly when their influence on AP-1 and NF-kB is taken into consideration. The differential targeting of these pathways also accounts for the separation between CSA and PD98059 and to a lesser extent for the separation of SB203580 and rottlerin. A comparative analysis of the differential targeting of drugs is further illustrated by the hierarchical clustering in Figure 6c , where profiling of the AP1 produces the greatest class distinction between IGF-1 vs wortmannin and CSA vs PD98059 ( Figure  6c ). Hierarchical clustering of the drug targeting for the remainder of the reporters is included as Supplement information (Supplement 6).
Data generated by this PTT can also be evaluated through simple pairwise comparison of the drug influence by analysis of variance (ANOVA) (Figure 6d and Supplement 7). This allows a rapid assessment of the transcriptional targets that would serve as the best discriminators of the different drug pairs. The statistical significance of relative drug discrimination by the reporters (P-value; Supplement 7) is analyzed by hierarchical clustering in Figure 6d . Here, NFAT/ AP1 is able to distinguish over 50% of the drug pairs with greater than 99% confidence followed by p300 (42%) and NF-kB (21%) (Supplement 7). Figure 6e is a four-dimensional representation of the data in Figure 6d that facilitates the query of pairwise drug comparisons.
Mapping Molecular Signaling Pathways to Patterns of Transcriptional Regulation
The ability of CSA to inhibit NFAT/AP1 activation by suppressing the calcineurin-mediated dephosphorylation that promotes its translocation to the nucleus is well described. 34 However, the inhibition of NF-kB by CSA has remained an unresolved issue. Prior observations of NF-kB repression by CSA have been reported but the mechanism was unexplained. 29, 35 A key regulatory event in NF-kB activation is the phosphorylation of the NF-kB inhibitor IkBa by I-kB kinase (IKK). This promotes I-kB protein ubiquitylation and subsequent degradation, allowing sequestered NF-kB dimers to enter the nucleus (reviewed in Karin et al).
36 Therefore, a likely point of NF-kB transcriptional pathway regulation by CSA would be at the level of IkBa phosphorylation. As shown in Figure 7a , early increases in the phosphorylation of I-kBa following mitogen stimulation of Jurkat cells (phorbol ester and ionomycin (P/I) or P/I plus aCD28 antibodies) are significantly inhibited in the presence of CSA. Interestingly, as has been reported previously, stimulation in the presence of aCD28 produces some resistance to the influence of CSA. 37 Similar repression of I-kBa phosphorylation is seen in primary T cells stimulated with aCD3 or aCD3 plus aCD28 antibodies, although the effects are much more pronounced during aCD28 costimulation (Figure 7b ).
Since the repression of I-kBa phosphorylation by CSA is rapid and detectable within minutes of mitogen stimulation, the mechanism of repression is likely to involve proximal events in the signaling pathways leading to I-kBa phosphorylation. Akt (protein kinase B) is a proximal intermediate that plays a significant role in promoting IkBa phosphorylation by IKK in mitogen-stimulated T cells (reviewed in Kane and Weiss 38 ). Recent findings that calcineurin stabilizes the active phosphorylation state of Akt suggest a plausible mechanism for CSA repression. 39 This idea is confirmed in Figure 7c , which shows that the early induction of Akt by aCD3 and aCD3/aCD28 is antagonized by CSA, thus providing a mechanism for the repression of NF-kB transcriptional pathways by CSA. Furthermore, the aCD28-costimulated increase in AKT phosphorylation partly explains the relative resistance of IkBa phosphorylation to CSA under these conditions ( Figure  7a and b) . This suppression of Akt phosphorylation by CSA represents a novel finding in human T cells, although it has been previously suggested in cells of renal origin. 39 How wortmannin and CSA are able to stimulate AP1 is puzzling. Analysis of the activating phosphorylation state of c-Jun following wortmannin treatment shows that c-Jun phosphorylation is upregulated in the presence of wortmannin, providing a plausible reason for the increase in transcriptional activity (Figure 7d ). How CSA increases the AP1 transcriptional activity is much more problematic. Several reports have shown that T-cell activation-dependent upregulation of Jun kinase (JNK) is inhibited by CSA 40,41 and our findings are consistent with CSA inhibition of Jun phosphorylation (data not shown). The increase in AP1 transcriptional activity must therefore involve other members of the AP1 family, including JunD, JunB, Fos, Fra1, and Fra2. Interestingly, CSA has been previously shown to upregulate the levels of c-fos during mitogen stimulation by preventing the calcineurin-dependent dephosphorylation of Elk1 41, 42 and recent studies by our group indicate that prolonged exposure (5 h) of activated T cells to CSA leads to elevated levels of JunD under conditions where the inducible levels of c-fos remain unchanged (CM Haggerty et al, unpublished observations).
Validation of Transcriptional Targeting
Transcriptional reporter assays in primary human T cells validate the prediction that IGF-1 synergizes with CD28-mediated signaling to activate NF-kB and CD28RE/AP1 transcription in activated T cells, as demonstrated in Figures  4b and 5 (Figure 8a ). Both the NF-kB reporter and the CD28RE/AP1 element of the IL2 promoter are cooperatively upregulated in the presence of IGF-1. The mechanism of this induction is mediated at least in part by increased phosphorylation of I-kBa since IGF-1 synergizes with both P/I /aCD28 and aCD3/aCD28 mitogen combinations to increase the phosphorylation of I-kBa (Figure 8a ). The preferential targeting of the CD28RE/AP1 element by IGF-1 suggests that other promoters containing sequences that resemble the CD28RE/AP1 might also be modulated by IGF-1. In fact, sequences closely related to the CD28RE/AP1 have been reported in the regulatory regions of other cytokine genes in addition to IL2. 43, 44 Figure 8b shows nine aligned promoter sequences that contain CD28RE/AP1 sequences (for additional genes containing matching CD28RE/AP1 elements, see Supplement 8). Phylogenetic conservation has been shown to be a very useful measure of the biological activity of a regulatory sequence. 45 Therefore, the genomic locations of eight of the nine CD28RE/AP1-like sequences in Figure 8b were mapped and annotated for their position and their relative conservation in man, chimp, dog, mouse, rat, and chicken (Figure 8c ). Note that each CD28RE/ AP1 module is located within the proximal promoter regions of the gene loci and each shows a relatively high phylogenetic conservation in comparison to surrounding sequences (Figure 8c, highlighted in red) .
Since the IGF-1-inducible CD28RE/AP1 element is preferentially located in evolutionarily conserved promoter regions of numerous genes important in immune cell function, the obvious implication is that IGF-1 could play a major role in modulating innate and adaptive immune cell function. To test this hypothesis, a focused proteomic screen was conducted where Jurkat T cells were costimulated with increasing concentrations of IGF-1 (0-600 ng/ml) in the presence of the 16 mitogen combinations (used in Figure 1) , and assayed for production of GM-CSF, IL1b, IL2, IL4, IL5, IL6, IL8, IL10, IL12p70, and TNF at 1, 2, and 5 h after stimulation ( Figure 9a ). As is evident in Figure 9a , IGF-1 produces changes in the cytokine production of IL5, IL6, IL2, IL8, IL10, and GM-CSF in Jurkat cells with multiple patterns of dose and time dependence.
The striking observations from the proteomic screen of IGF-1-costimulated Jurkat T cells are supported further by a focused gene expression study of donor human T cells stimulated for 24 h with either aCD3 alone or with aCD3 and IGF-1. The expression profiles were then analyzed using a spotted cDNA 'immunomicroarray' 46 containing a concentration of genes involved in immune cell function (Figure 9b) . Here, costimulation with IGF-1 causes significant upregulation of numerous genes clustered in Figure 9b according to fold induction.
Thus, both proteomic and gene expression profiling provide convincing evidence that IGF-1 plays a major role in the transcriptional regulation of genes important in immune function. Moreover, most of the genes upregulated at the protein level showed upregulation on the immunomicroarray (four of seven) (Supplement 8). This included IL2, IL8, IL12, and CSF2 (IL15 and IL10 were not represented on the immunoarray) (Supplement 8) . To see what percentage of the regulated genes on the immunoarray contain the IGF-1-responsive CD28RE/AP1 element in conserved promoter regions, 1300 bp regions (À1200 to þ 100 bp from the transcription start site (TSS)) were extracted from all the genes on the immunoarray and scanned for the presence of the CD28RE/AP1 element in conserved regions. Positive promoters were scored by the level of homology and relative conservation in chimp, mouse, rat, and chicken (Supplement 8). By this analysis, a significant fraction of the regulated genes contain the potential IGF-1-controlled CD28RE/AP1 module. Each gene cluster was then given a score based on the percentage of promoters containing the CD28RE/AP1 site, and the product of scores for the CD28RE/ AP1 sequence similarity and phylogenetic conservation for those sites with conservation greater than 40% of the maximum score (Materials and Methods and Supplement 8). This similarity/conservations score could significantly distinguish most of the IGF-1-induced clusters from a random gene list or the list of unchanged genes (Table 2) . Thus, statistically significant association exists between IGF-1 inducibility and the presence of CD28RE/AP1 modules in phylogenetically conserved regions within the promoters of the genes surveyed in Figure 9b .
DISCUSSION
PTT is a powerful cell-based approach that combines signal transduction pathway profiling with active transcriptional data capture in a functional genomic context. In addition to providing a platform for pathway discovery and drug target evaluation, this combination also establishes a firm foundation for hypothesis generation and testing. The systematic methods inherent in PTT are well suited for assessing drug efficacy, and the flexibility of its analytical format will help formulate perspectives and insights that will guide the selection of useful biomarkers and surrogate tissues for therapeutic testing. Because the transcriptional profiling is interpreted in a genomic context focused on cis-element composition, PTT will also lay the conceptual groundwork for developing new paradigms for understanding population-based differences in drug and therapeutic response. In the current work, PTT was used to develop a functional data base that distinguishes the selective transcriptional pathway-specific targeting of numerous immunomodulatory agents known or suspected to influence transcriptional networks induced during T-cell activation. In addition to revealing important aspects of the mechanisms of transcriptional targeting by these agents, PTT also highlights the essential role of 'promoter logic' in the fundamental understanding of how regulatory element composition functions to integrate the various molecular signals that converge to influence transcriptional outcome. The application of this approach has also led to the identification of IGF-1 as an important mediator of transcriptional control in activated T cells, and implicated a genomic sequence, conserved in numerous immune-function-related genes, as a potential target and marker for IGF-1-controlled gene regulatory pathways.
In addition to illustrating that PTT can function as a robust drug screening tool, this work has also highlighted some very interesting gaps in our understanding of the mechanism of action of numerous agents. One unexpected finding was the ability of the PI3-kinase inhibitor wortmannin to cause upregulation of the AP1 pathways. This finding may be explained in part by the observation that several upstream kinases in control of the phosphorylation-dependent activation of AP1 are regulated, to some extent, by PI3-kinase-dependent pathways. For example, the downstream effector of PI3-kinase, Akt, induces upregulation of JNK interaction protein (JIP), which subsequently causes JNK repression. 47 Akt has also been shown to inhibit Jun phosphorylation via direct downregulation of a JNK-activating kinase, apoptosis signal-regulating kinase 1 (ASK1), a member of the mitogen-activated protein kinase kinase kinase (MAPKKK) family 48 (see Figure 9c) . Finally, another MAPKKK, Cot-1/Tpl2, is an upstream regulator of JNK activity that exerts divergent control over NF-kB and AP1. 49 Cot-1/Tpl2 activation of NF-kB, but not AP1, requires Akt. This divergence could give rise to a reallocation during mitogen induction where PI3-kinase activity exceeds a threshold through activated Akt that preferentially redirects Cot-1/Tpl2 kinases along pathways that induce IKK. 49 Such dynamic 'shunting' of Cot-1/Tpl2 toward IKK pathways could effectively sequester it from pathways that increase AP1 phosphorylation, thereby attenuating AP1 transcriptional activity. Repression of Akt activation by wortmannin would therefore result in redistribution of Cot-1/Tpl2 with subsequent preferential activation of AP1 (Figure 9c ). These mechanisms of negative regulatory control of AP1 by PI3-kinase may account for the inhibitory PI3-kinase/Akt pathways reported to function in activated T cells. 50 The manner in which CSA is able to induce AP1 activity is in contrast to previous reports that CSA represses JNK activation. 51, 52 As mentioned previously, CSA does repress Jun phosphorylation under the condition of activation used in the current study; therefore, an alternative pathway to AP1 activation must exist. Potential components of this pathway include CSA-induced increases in c-Fos expression 42 and the elevation in JunD levels that we observe in extracts derived from cells stimulated in the presence of CSA (CM Haggerty et al, unpublished observations). Recent findings indicating that JunD AP1 activity can be stimulated by Erk independent of JNK 53,54 suggests a possible role for Erk in this activity. Notwithstanding, the discordance between c-Jun phosphorylation and AP1 activation highlights the importance of using functional assays to assess transcriptional pathway activation when evaluating molecular drug targeting. This is particularly important when evaluating transcriptional pathways controlled by multiple family members with overlapping and redundant function. It should be noted that few, if any, reports of the inhibitory effect of CSA on JNK showed a functional correlation between the JNK inhibition and the stimulus-evoked transcriptional activity of an AP1 reporter.
Other observations that will require mechanistic followup in the future include the inhibition of the transcriptional activation properties of C-terminal domains of p300 by CSA Figure 9 Focused proteomic and genomic screening reveals broad regulatory role for IGF-1 in activated T cells. (a) Jurkat T cells were stimulated with 16 mitogen combinations (see Figure 1 ) for 1, 2, and 5 h in the presence of 0, 40, 160, and 600 ng/ml IGF-1. Relative protein levels of GM-CSF, IL1b, IL2, IL4, IL5, IL6, IL8, IL10, IL12p70, and TNFa were then determined (Materials and methods). Levels were compared by hierarchical clustering. The predominating cytokines in the major clusters are labeled. (b) Primary T cells from three different donors were stimulated with aCD3 for 24 h in the presence or absence of 50 ng/ml IGF-1. mRNA was isolated and analyzed using a immunomicroarray. 46 Gene expression levels were compared by hierarchical clustering. Relative positions of clusters with two-fold or greater upregulation over aCD3 alone are indicated. ( Figure 2c and 5b) and the induction of CREB pathway activity in the presence of wortmannin (Figures 1c, 2a, 3 , and 5b). Akt is known to target the C-terminal domains of p300 and may therefore provide an explanation for p300's sensitivity to CSA. 55 The induction of CREB pathways by wortmannin is in contrast to reports that PI3-kinase/Akt signaling can induce CREB activity. However, the CREB family is very large with many redundant and overlapping members including some that play a dominant-negative role (eg ICER 56 ) in regulating CREB pathway activation. 57 Determining the mechanism underlying this mode of regulation will require extensive investigation.
IGF-1 is an important small peptide hormone with a widely recognized role in the control of cell growth metabolism and cellular differentiation. 58, 59 Elevated serum levels of IGF-1 are associated with a variety of human malignancies [58] [59] [60] IGF-1 and its receptor have therefore become attractive targets for the development of strategies for therapeutic intervention. 61 However, despite its broad role in modulating cell function, and recent studies suggesting a role for IGF-1 in childhood leukemias, 62 the influence of IGF-1 on adaptive immune cell function and biology has been relatively unstudied. Using PTT in an unbiased approach, we have found the IGF-1 can act as a potent costimulus during T-cell activation that increases NFkB transcriptional activity and selectively targets a composite site (CD28RE/AP1) present in phylogenetically conserved promoter regions of numerous immune-active genes ( Figures 5 and 8 ). To support a broad role for IGF-1 in T-cell function, we provided evidence from focused proteomic and gene expression screens that IGF-1 can induce the expression of many different genes important in immune function at both the RNA and protein level (Figure 9a and b) . Although the proteomic analysis was carried out in very short time intervals (1-5 h) , the gene expression screen using IGF-1 as a costimulus was conducted over a 24 h period. Thus, it is likely that many of the genes upregulated in Figure 9b will be found to be indirect targets of the action of IGF-1. This is especially likely since many of the genes upregulated by IGF-1 in this study are cytokine genes known to influence gene expression in T cells (Supplement 9). Wellknown downstream effectors of IGF-1 signaling involve the PI3-kinase/Akt pathway; thus, many of the drug interactions described in this current work will certainly impinge on IGF-1 signaling, especially wortmannin and CSA. Other known IGF-1-regulated pathways that will have to be evaluated in T cells include the various limbs mediated through Ras/Map kinase, Jak/stat, and beta-catenin networks. 63 Although the gene expression array used in this study contained a biased selection of immune-active genes, when the list of IGF-1-induced genes was analyzed using a regulatory pathway knowledge data base developed by Ingenuity Systems (Ingenuity Pathway Analysis Application), 64 a regulatory network was identified in which all 35 of its members were empirically determined to be functional targets of IGF-1 (Figure 9d ). This regulatory network, its members, functional relationships, and classifications are shown in Figure 9d . Many centrally linked features of this network are members of the NF-kB family of transcription factors while others are either linked to NF-kB signaling or have roles in PI3-kinase/Akt signaling, survival, and apoptotic pathways. These findings clearly demonstrate the strong functional link between IGF-1 signaling and NF-kB in T cells. Given the pleiotropic actions of IGF-1, future PTT studies of IGF-1 signaling in T cells will have to be evaluated in a broader context with expanded examination of transcriptional targets representing other pathways including Stat, beta-catenin, C/EBP, and ets.
In summary, the predictive power of PTT illustrates its usefulness as both a screening tool for new therapeutic strategies and a platform for the identification of unrecognized molecular signaling pathways and control points. Although transient transfection data sets provide limited information about chromatin structure, their simplicity allows more precise determinations of targeted transcriptional pathways. This method is therefore well suited for large-scale functional screening of potential regulatory elements within intergenic sequences spread throughout the human genome. Future applications that will augment this approach include methods that measure activated transcription in the context of chromatin, such as nuclear run-on assays and chromatin immunoprecipitation analyses.
MATERIALS AND METHODS
Plasmids IL2 luciferase reporter plasmid was constructed by insertion of HindIII IL2 CAT reporter fragment in PGL3 basic (Promega, Madison, WI, USA). AP1, NF-kB, and CRE (CREB) luciferase reporters were purchased from Stratagene (La Jolla, CA, USA). NFAT/AP1 luciferase reporter was a kind gift from Dr James Goodrich. CD28RE/AP1 luciferase reporter was a generous gift from Dr Arthur Weiss. 10 The UAS luciferase reporter and GAL4 DNA binding domain p300 fusion constructs, full length (p300FL, UAS/FL), and the first 743 amino acids of p300 (p300 N-term, UAS/1-743) were previously described. 65, 66 Cell Culture and High-Throughput Transfections Jurkat T cells were maintained in RPMI media (Gemini BioProducts, Woodland, CA, USA) containing 10% fetal bovine serum at 371C, 5% CO 2 in 2 l roller bottles. High-throughput transfections of Jurkat T cells were performed in triplicate by electroporation using the BTX ECM 830 multi-coaxial 96-well electrode (Genetronics Inc.). A total of 10 million Jurkat T cells in 100 ml of RPMI 1640 were mixed with 20 mg of the appropriate plasmid DNA per transfection in each well of a standard flat-bottomed 96-well plate. After electroporation at 260 V with a 50 ms pulse, cells (5 Â 10 6 cells/ml) were incubated with indicated mitogen/drug combinations. Concentrations of the mitogens and drugs used are as follows: 50 ng/ml phorbol 12-myristate 13-acetate (PMA) (Sigma, St Louis, MO, USA), 720 ng/ml ionomycin (Calbiochem, San Diego, CA, USA), 1 mg/ml PHA (Amersham Pharmacia, Piscataway, NJ, USA), 1 : 1000 dilution of anti-CD3 filtered from OKT3 ascites (ATCC, Manassas, VA, USA), 1 : 1000 dilution of anti-CD28 monoclonal antibody (a generous gift from Dr Carl June), 0.5 mg/ml anti-CD28 (Research Diagnostics Inc.), 5 mM CSA (Sandoz, Vienna, Austria), 100 mM forskolin (Sigma), 40 ng/ml IGF-1 (Research Diagnostics Inc., Flanders, NJ, USA), 10 mM PD98059 (Calbiochem), 10 mM rottlerin (Sigma), 10 mM SB203580 (Calbiochem), and 5 nM wortmannin (Calbiochem). After 5 h incubation, cells were harvested and lysed in 100 ml reporter lysis buffer (Promega, Madison, WI, USA). Luciferase and protein assays were performed as previously described. 67 Human Primary Blood Lymphocyte Transient Transfections Primary blood lymphocytes (PBLs) were obtained by Leukopak Processing. Cells contained in Leukopaks were washed with PBS, underlaid with Lymphocyte Separation Medium (ICN, Costa Mesa, CA, USA), and then centrifuged at 400 g for 30 min at room temperature. Lymphocytes were transfected with 5 mg promoter reporter using the Human Tcell Nucleofector Kit (Amaxa Biosystems, Koeln, Germany) as directed by the manufacturer. Treatment conditions were same as those described above.
Normalization and Data Analysis
Each 96-well plate contained cells transfected with one of the eight promoter module reporters. The top 48 wells contained the treatments that we refer to as the control profile, which includes unstimulated and 15 mitogen combinations in triplicate (see Figure 1a and c for list). For each 96-well plate, the bottom 48 wells were a replicate of the top except that the appropriate drug was added. Transcriptional activation was determined by measuring the luciferase activity normalized by total protein levels. Next, replicate normalized luciferase results were averaged and fold activation over measurement in unstimulated cells for each promoter module reporter was calculated. Percent maximum change in transcriptional activity was calculated to normalize among plates and account for interexperiment variability in electroporation efficiency and/or magnitude of cell stimulation. The mitogen combination (see Figure 1c for list) yielding the highest fold activation in the absence of drug was the 100% maximum reference. PCA, unsupervised neural networks (SOM), and hierarchical clustering were all performed using percent maximum data. Since there were triplicates of unstimulated and mitogen-treated control data for each of the eight promoter reporters and seven different drugs used (see Figure 1C for list), each data point in the control profile of the hierarchical clustering and PCA (Figures 2-6 ) was obtained by averaging triplicates from 56 plates. The average standard error for all measurements in the entire experiment was less than 19% of the mean, with a median of 18% of the mean.
Statistical Analysis Software PCA and intensity plot construction were performed using Partek Pro 5.1. (Partek, St Louis, MO, USA). MMC GeneLinker Gold (Molecular Mining Corporation, Raleigh, NC, USA) was employed for hierarchical clustering, dendrogram assembly, and unsupervised neural network analyses (SOM).
Antibodies and Immunoblot Analysis
All antibodies (Ik-Ba, phospho-I-kB, Ser32, Ser36, c-Jun, phospho-c-Jun Ser63, Akt, and phospho-Akt Ser473) were purchased from Cell Signaling Technology Inc. (Beverly, MA, USA). Jurkat T-cells and PBLs were stimulated and drug treated as indicated for 15, 30, 45, or 60 min. Zero time points represent unstimulated and untreated cells. After two PBS washes, cells were lysed in a modified RIPA buffer containing 50 mM Hepes, 20 mM sodium pyrophosphate, 25 mM b-glycerophosphate, 50 mM sodium fluoride, 5 mM sodium molybdate, 5 mM EDTA, 150 mM orthophenanthroline, 1% NP-40, 0.5% deoxycholate, 1% Triton X-100, mammalian protease inhibitor (Sigma, St Louis, MO, USA), and 0.2 mM Na 2 VO 4 . BCA protein assays were performed (Pierce, Rockford, IL, USA) and 10-30 mg of lysate was used for Western analysis. Western blots were performed following the manufacturer's protocol (Cell Signaling Technology Inc., Beverly, MA, USA). Following ECL detection (Amersham Pharmacia, Piscataway, NJ, USA), band intensities were assessed using ImageQuant 5.2 (Molecular Dynamics, Amersham Pharmacia, Piscataway, NJ, USA).
Microarray Analysis
Gene expression was determined from duplicate microarray experiments using the NIA immunomicroarray. A defined set of 1152 immune response-related cDNAs were PCR amplified and printed onto nylon filters. 46 Pixel densities of 33 P-labeled cDNA hybridization signals were captured for quantitation on a Storm PhosphorImager (Molecular Dynamics/Amersham, Piscataway, NJ, USA) and analyzed by means of QuantOne Image Software (Bio-Rad). Mean values from raw densities from each experiment were normalized by dividing the resulting values of each measurement by the median of the CD3-induced signal from all three donors for each gene. Data were then analyzed by hierarchical clustering using a Euclidean distance metric with average linkage. Mean values of raw data are provided as Supplement information (Supplement 9).
Promoter Analysis
Promoter sequences (1300 bp regions, À1200 bp from TSS to þ 100 bp from TSS) were extracted from UCSC/NCBI assembly build 28 of the human genome with the Genome Analysis Tool 'the promoter regions of RefSeq sequences' http://genome.nci.nih.gov/tools/promoH.html. Identification and similarity scoring of CD28RE/AP1 promoter modules in the extracted sequence were performed using the ModelInspector module of the GEMS LAUNCHER 3.8 (Genomatix, Munich). 68 Module matches were scored when a consensus sequence with a Genomatix MatInspector position weighted matrix match for NF-kB consensus binding site (V$NFKB) was located within 20 bp of a Genomatix MatInspector position weighted matrix match for AP1 or CREB consensus binding sites (V$AP1 or V$CREB) with a calculated consensus matching score (module score) from 0 to 100 (100 ¼ perfect consensus match). 69 Regions containing the CD28RE/AP1 were evaluated for evolutionary conservation in chimp, mouse, rat, and chicken by scoring the BLAT retrieved sequences containing the matching CD28RE/AP1 flanked by 50 bp of sequence (July 2003 UCSC/NCBI assembly) using a phylogenetic hidden Markov model scoring system provided by the USCS Genome Browser at http://genome.ucsc.edu/cgi-bin/hgBlat. Retrieved module scores from ModelInspector and the conservation scores from the USCS Genome Browser were normalized by scaling to percent maximum (0.0-1.0). Significance scores for gene clusters were determined by multiplying the product of the normalized median module score and conservation scores for each promoter region with a conservation score 40.4 by the ratio of the total matches for the CD28RE/AP1 module in the retrieved promoter regions of each respective gene cluster. The random list of gene promoters was generated from a list of 100 genes randomly selected from a list of 10 000 named genes included on the NCI microarray http://nciarray.nci.nih.-gov/cgi-bin/gipo (see Supplement 8) .
Proteomic Analysis
Cytokine measurements were carried out on triplicate independent cell supernatants using Meso Scale Discovery (MSD) Multi-Spott plates and an MSD Sector Imager 6000 reader (Meso Scale Discovery, Gaithersburg, MD, USA). A total of 10 cytokines were measured simultaneously in each well of 96-well plates using MSD's 10-Plex Human Cytokine Panel (GM-CSF, IL1b, IL2, IL4, IL5, IL6, IL8, IL10, IL12p70, and TNFa) according to the manufacturer's instructions.
